Dr. Raphael Ezera Nwojo, MD

Dr. Nwojo practices at The Orthopedic Institute of Midland, L.P. in Midland, Texas.

Dr. Nwojo's NPI, 1891083689, was assigned on July 14, 2011. Dr. Nwojo graduated from McGovern Medical School in 2011. Dr. Nwojo's Texas license number on file is Q6353.

Dr. Nwojo's primary practice is The Orthopedic Institute of Midland, L.P., at 5609 Deauville Blvd, Midland, TX 79706 in Midland County. The practice phone is (432) 699-4224.

Dr. Nwojo's primary practice is The Orthopedic Institute of Midland, L.P. in Midland, Texas. Dr. Nwojo is also affiliated with Midland Memorial Hospital. The medical group on file is West Texas Ear, Nose, Throat and Sinus Institute. Dmand AI also links Dr. Nwojo to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nwojo practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Nwojo's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Nwojo is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Nwojo's licenses on file in 2 states: Texas and Florida.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. Nwojo treats.

CMS data shows 1,312 Medicare services from Dr. Nwojo across 19 procedure codes in 2024, for 377 Medicare patients. Medicare paid $147,587 for them. Every service was in an office.

CMS counts 377 Medicare patients who saw Dr. Nwojo in 2024. The largest group is 65 to 74, with 189 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nwojo's median patient age at 55, with 53% women.

In 2024, Dr. Nwojo wrote 791 Medicare Part D claims for 270 patients. 91% of them were for generic drugs. CMS names the drug for 649 of them, across 21 drugs with 11 or more claims each, at $9,551 in total drug cost. In 2023, CMS named 634 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Nwojo for performance year 2024, reported as part of a group. Dr. Nwojo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Nwojo, published from 2011 to 2020. 2015 was the busiest year, with 2. Dr. Nwojo's most frequent co-authors are Joshua M. Hare, FACC, MD, Swapna Kolli, MD and Joshua Ronen, MD.

CMS Open Payments shows 173 general payments to Dr. Nwojo from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 54% of the total. Intersect ENT, Inc. paid the most, $2,392.

Dr. Nwojo graduated from McGovern Medical School in 2011.

Dr. Nwojo is in network with 17 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.